ClinicalTrials.Veeva

Menu

The Influence of Oral Probiotic on the Vaginal Flora and Microenvironment Alteration in the Vaginosis Infection Women

Chang Gung Medical Foundation logo

Chang Gung Medical Foundation

Status

Enrolling

Conditions

Probiotic, Human Papillomavirus Infection, Pap Smear, Microbiome

Treatments

Dietary Supplement: probiotic:Lactobacillus crispatus

Study type

Interventional

Funder types

Other

Identifiers

NCT06001190
CORPG6M0171

Details and patient eligibility

About

A single-blind, randomized, and probiotic-treatment including adult women with vaginitis and/or HPV positive. After oral probiotics, all participants will be followd-up cervical swabs and vaginal microbiome alteration till the end of the study.

Enrollment

76 estimated patients

Sex

Female

Ages

20 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • diagnosed as vaginal viginitis
  • willing to sign permit
  • willing to regular follow up

Exclusion criteria

  • Pregnant
  • Virgin
  • Severe cervix pathology CINII or CIN III
  • Confirmed cervical cancer
  • under long term antibiotics due to other physical condition

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

76 participants in 2 patient groups, including a placebo group

probiotic intervention
Active Comparator group
Description:
probiotic group with daily treatment
Treatment:
Dietary Supplement: probiotic:Lactobacillus crispatus
placebo
Placebo Comparator group
Description:
placebo-controlled with daily treatment
Treatment:
Dietary Supplement: probiotic:Lactobacillus crispatus

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems